Frederic Arnold

Current Position

Postdoctoral Fellow

Academic Education

2006 - 2013

Medical School (Freiburg, Zürich, Tampa, FL)

Advanced Qualifications

2024	Board Certification in Nephrology
2020	Board Certification in Internal Medicine
2017	Doctoral degree in Medicine (Dr. med.), University of Freiburg

Postgraduate Positions

2019 - present	Postdoctoral Research Fellow (Berta-Ottenstein-Programme for Clinician Scientists), Renal Division & Institute for Microbiology and Hygiene, Medical Center - University of Freiburg
2020 - present	Fellow in Nephrology, Medical Center - University of Freiburg
2014 - 2020	Residency in Internal Medicine, Medical Center - University of Freiburg
2014	Residency in Internal Medicine / Neurology - Center for paraplegics and brain injuries, REHAB, Basel, CH

Link to all publications of Frederic Arnold: PubMed

Publications on CRC 1453 funding

Grahammer F, Dumoulin B, Gulieva RE, Arnold F, …, Freedman BS, Busch H, Boerries M, Walz G, Huber TB. Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity. Kidney Int (2024). Arnold F, Kupferschmid L, Weissenborn P, …, Zareba P, Sagar, Rogg M, Schell C, Tanriver Y. Tissue-resident memory T cells break tolerance to renal autoantigens and orchestrate immune-mediated nephritis. Cell Mol Immunol (2024). Arnold F, Kappes J, Rottmann FA, Westermann L, Welte T. HbA1c-dependent projection of long-term renal outcomes. J Intern Med (2023). Westermann L, Rottmann FA, Hug MJ, Staudacher DL, Wobster R, Arnold F, Welte T. Clinical covariates influencing clinical outcomes in primary membranous nephropathy. BMC Nephrol (2023). Welte T, Westermann L, Kappes J, Schramm MA, Bemtgen X, Staudacher DL, Hug MJ, Venhoff N, Arnold F. Identification of covariates modulating B-cell repopulation kinetics in subjects receiving rituximab treatment. Arthritis Rheumatol (2023). Thelen B, Schipperges V, Knörlein P, Hummel JF, Arnold F, …, Arnold SJ, Börries M, Tanriver Y. Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4+ T cells. Front Immunol (2023). Welte T, Arnold F, Westermann L, Rottmann FA, Hug MJ, Neumann-Haefelin E, Ganner A. Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study. BMC Nephrol (2023). Arnold F, Huzly D, Tanriver Y, Welte T. Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune disease. BMC Infect Dis (2022). Tanriver U, Emmerich F, Hummel JF, Jänigen B, Panning M, Arnold F, Tanriver Y. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study. Clin Transplant (2022).